OXFORD UNIVERSITY INNOVATION SPONSORS THE PLANTING OF A TREE IN Wytham Woods IN HONOUR OF OIA'S LAUNCH
Coinciding with OIA's first anniversary this past September 25th, Oxford University planted a 4-year old small beech tree in honour of Oxford Immune Algorithmics (OIA) at the Oxford University premises in Wytham Woods, Oxford, UK where a plaque dedicated to OIA was unveiled. The tree will be taken care of for 15 years after which the plaque will be placed on the base of the tree for the hundreds of years that the tree will hopefully live and for next generations to take care. This is an initiative to create awareness and help replant an area of the woods.
Young trees like these ones can absorb CO2 much faster than larger trees as their metabolism is faster between 4 and 15 years old. Our ambitious goal at OIA for the next 15 years is to become the leaders in healthcare technology and offer an affordable scalable solution to help cure all curable human diseases. Helping plant the tree were personnel from Oxford University Innovation and OIA, including OIA's CEO Dr. Hector Zenil. OIA is honoured to have received this distinction from the 8 startups and spinouts from Oxford University that launch in average every year.
OIA will be at the the early stage life sciences investment event to be held at Level39 in Canary Wharf, London, January 20, 2020.
On the 15-16 October 2019, OIA is attending The Global Innovation and New Technology Health Event at the Chelsea Football Club Stadium in London where it is showcased the leading health tech startups from around the world.
An application of our research in causal models in molecular biology has been published today in one of the finest journals in molecular biology, Nucleic Acids Research (Oxford). This is the first meaningful application of algorithmic complexity to experimental cell biology beyond previous methods based on statistical approaches. It strengthens our position as pioneers in the area of causal knowledge discovery and it propels us forward as a validation of our work and technology.
Our paper shows how our methods identify DNA sequences holding key information about genetic regulation.
We have been growing at an exciting rate and we have moved offices three times already only this year. We have now opened our new AI-biomedical lab this month and we are already thinking of expanding it. We have here some pictures of how the the lab looks like today.
OUR NEW paper published in iscience (cell press) lays out the foundations of our technology TO BETTER DEAL WITH CAUSALITY IN MOLECULAR BIOLOGY & immunology to make a real impact in the future of healthcare
We are heading to #TuringFest19 in Edinburgh this August. OIA has been invited to participate in the Turing Founders event where startups and new companies meet investors.
OIA has been invited as a VIP guest to the 3rd annual In-Memory Computing Summit Europe, on June 3 & 4, at the Park Plaza Victoria in London where we will be promoting our science and technology.
We were invited to introduce OIA and present our work on AI for healthcare at the Thames Valley Artificial Intelligence meetup organised by Barclays AI Frenzy and Innovation Catalyst, University of Reading.
OIA INVITED TO the global ai & big data world EXPO in london, u.k. TO DELIVER A TALK ON CAUSAL MACHINE LEARNING IN HEALTHCARE
Invited by the organisers, Dr. Zenil (CEO) presented our research on AI for medicine at the World Expo on AI, Big Data & IoT at the Olympia Exhibition Centre on the 25th April in London, U.K.
Jürgen Riedel (CTO), Mariana González (Quality Manager) and Jasper Riedel attended the expo, representing OIA
We were honoured to present our algorithms and novel approaches to machine learning, healthcare and personalised medicine at the Datageeks Data Day 2019 sponsored by BMW, Airbus, and AID at the impressive BMW IT Zentrum (ITZ) in Munich, Germany before a crowd of 600 people. Jürgen Riedel (CTO), and Emil Melikov (Software Development Director) from OIA attended the conference and were instrumental in its organisation.
OIA's director, Dr. Zenil, presenting at BMW's IT headquarters in Munich, 9 March 2019
We had a successful meeting with our >1K people group (UK-AI Innovation) in East London to explain our most recent results in Artificial Intelligence and Machine Learning, their potential to transform academia and industry including healthcare, and also their current limitations and challenges. Subscribe to our UK-AI Innovation group led by Oxford Immune Algorithmics (OIA).
Drs. Jürgen Riedel and Hector Zenil from Oxford Immune Algorithmics and Mark Needham from Neo4j delivering talks on the state of AI, ML, and DL, use of network representations, challenges and limitations of technology.
Signed by Oxford Immune Algorithmics, these new two papers show how we are trying to transform healthcare with science technology:
- A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction
Nature Communications (accepted) (NPG)
- Causal Deconvolution by Algorithmic Generative Models
Nature Machine Intelligence, vol 1, pages 58–66, 2019 [online]
And a video that the Nature journal prepared to explain our paper and research.